The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1080

This is an MJF funded pre-clinical study by Samsara Therapeutics.

This is a funded pre-clinical study, investigating a similar mechanism of action to MPL.
They hope to get a clinical trial up & running in 2025.
With regards to comments above, going straight to phase 2 would provide a massive advantage over Samsara.
They are running separate pre-clinical trials to try & establish safety & toxicology.

So, they are way behind us in drug development - but it does demonstrate level of interest is high enough to attract funding.